Enterprise procurement pathways featuring proprietary screening platforms, potency evaluation models, and validated pharmacological matrices.
In the modern international pharmaceutical and dietary supplement ecosystem, sourcing highest quality ingredients requires overcoming strict regulatory thresholds, batch variability, and fragmented supply lines.
Global buyers enforce non-negotiable thresholds for residual solvents, polycyclic aromatic hydrocarbons (PAHs), heavy metals (ICP-MS testing for Pb, Cd, As, Hg), and pesticide multi-residue panels compliant with USP <561> and EP 2.8.13.
Industrial brands require chromatographic similarity indexes (>0.95) using High-Performance Thin-Layer Chromatography (HPTLC) and Ultra-High Performance Liquid Chromatography (UHPLC) to assure therapeutic consistency across consecutive commercial campaigns.
Every active compound must come equipped with complete Chemistry, Manufacturing, and Controls (CMC) technical files, Drug Master Files (DMF), stability testing protocols (ICH Q1A), and comprehensive botanical identity authentications.
Global procurement directives strictly require complete traceability back to GAP-certified cultivation bases, seasonal harvesting records, and validated physical extraction workflows that omit synthetic adulterants.
Bridging the critical transition from lab-scale ethnobotanical discovery to commercial GMP output through unified chemical engineering and translational clinical science.
Our extraction engineering utilizes supercritical CO2, macroporous resin adsorption, countercurrent chromatography, and ceramic membrane nanofiltration to concentrate target bioactive fractions (alkaloids, polyphenols, polysaccharides, saponins) while eliminating unwanted ballast matter.
We deploy dual-column HPLC-MS/MS, GC-MS, and high-resolution NMR spectroscopy to resolve structural ambiguities, detect positional isomers, and validate precise molar concentrations in raw materials and finished botanical formulations.
We solve the fundamental kinetic barriers of botanical compounds—poor water solubility, first-pass hepatic metabolism, and degradation in gastric fluids—through self-emulsifying drug delivery systems (SEDDS), phytosome microencapsulation, and solid dispersions.
Built on 14+ years of specialized contract research and pharmaceutical manufacturing across China's elite medical institutions.
Our long-term R&D trajectory integrates synthetic biology, AI predictive modeling, and continuous flow engineering to reshape active ingredient production.
Employing machine-learning molecular docking and network pharmacology to predict biological targets of complex polyherbal mixtures prior to wet-lab bioassays.
Migrating from traditional batch thermal percolation to continuous flow cavitation and microfluidic shearing, reducing thermal degradation of thermolabile molecules by 42%.
Engineering microbial chassis (engineered S. cerevisiae) to biosynthesize rare, endangered botanical secondary metabolites with 99.8% structural concordance.
Implementing decentralized cryptographic ledgers linking satellite agronomic weather data, field harvest batches, and final HPLC release assays directly to consumer QR codes.
Cross-border distribution demands total conformity with destination jurisdictions. MedGence ensures that raw materials and finished items pass rigorous multinational audits.
Full support for New Dietary Ingredient (NDI) notifications and Generally Recognized As Safe (GRAS) self-affirmations, supported by toxicological dossiers and master manufacturing records (MMRs).
Providing European Food Safety Authority compliant monographs, historical consumption documentation, and validated zero-solvent residue verification for EU Article 4 Novel Food compliance.
Manufacturing infrastructure structured to align with Therapeutic Goods Administration (TGA) Good Manufacturing Practice requirements, supporting Australian Listed and Registered formulations.
Deep institutional heritage navigating National Medical Products Administration regulations, hospital preparation filings, and modernized Traditional Chinese Medicine submissions.
Our analytical and contract manufacturing pipelines provide verified ingredients for 30+ publicly traded corporations and state teaching hospitals.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtzi River Pharma
Beihai Gofar
Humanwell Healthcare
SCIMYTH Pharma
Hanfang Pharma
Luoxin Pharma
Clear, technical information addressing quality release, proprietary IP, analytical methodologies, and commercial OEM scale-up.
Explore contract manufacturing and validated preclinical/clinical study modules for immediate global project initiation.
